QHQunqi Hu

Qunqi Hu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qunqi Hu has a total of 41 co-authors. Here are the top co-authors by number of shared publications:

  • Xiaofen He

    Key Laboratory of Acupuncture and Neurology of Zhejiang Province, Department of Neurobiology and Acupuncture Research, The Third Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China

    3 shared publications
  • Han-Zhi Wang

    Key Laboratory of Acupuncture and Neurology of Zhejiang Province, Department of Neurobiology and Acupuncture Research, The Third Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China

    2 shared publications
  • Hanzhi Wang

    Department of Gynecology, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, 310012, People’s Republic of China

    2 shared publications
  • Jianqiao Fang

    Department of Neurobiology and Acupuncture Research, The Third Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China

    2 shared publications
  • Si-Ying Qu

    Key Laboratory of Acupuncture and Neurology of Zhejiang Province, Department of Neurobiology and Acupuncture Research, The Third Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China

    2 shared publications
  • Siying Qu

    Key Laboratory of Acupuncture and Neurology of Zhejiang Province, The Third Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, People’s Republic of China

    2 shared publications

Latest Publications

  • Open Access

    Predictive Value of the Triglyceride-Glucose-Frailty Index for Depression and Cognitive Function in Perimenopausal Women: Insights from CHARLS

    by Hengyu Chi, Qunqi Hu, Jingqi Liang, Jingjing Zhang, Siying Qu, Hanzhi Wang, Yurong Kang, Zhouqi Liu, Yuran Chen, Yongliang Jiang, et al.

    Purpose: Perimenopause represents a critical neuroendocrine transition stage in the lives of women, characterized by metabolic disorders and physiological vulnerability, which also commonly manifests as depression and cognitive impairment. This study explores associations between the triglyceride-glucose-frailty index (TyGFI) and depression/cognitive impairment in perimenopausal women. Methods: Data were obtained from the 2015 China Health and Retirement Longitudinal Study (CHARLS) and 2,596 perimenopausal women were included. Logistic regression models were used to evaluate the association between TyGFI and depression/cognitive impairment. Restricted cubic spline (RCS) curves were plotted to visualize the dose–response relationship. Subgroup analyses and receiver operating characteristic (ROC) curves were used to assess interaction effects and evaluate the discriminatory ability of TyGFI. The results were expressed as odds ratios (OR) with 95% confidence intervals (CI). Results: Perimenopausal women with higher TyGFI levels exhibited a greater tendency towards depression and cognitive impairment, older age, higher blood pressure, and poorer self-reported health. In the fully adjusted model, each one-point increase in TyGFI was associated with elevated risk of depression (OR = 3.70, 95% CI: 3.18– 4.32) and cognitive impairment (OR = 1.51, 95% CI: 1.34– 1.71). RCS curves confirmed non-linear, positive associations and clear dose–response trends. Subgroup analysis revealed that the associations remained largely robust across most subgroups. ROC analysis demonstrated moderate-to-good discriminatory ability, with area under the curve (AUC) of 0.786 for depression and 0.634 for cognitive impairment. Conclusion: The TyGFI was concurrently correlated with depression and cognitive impairment in Chinese perimenopausal women, which may serve as a potential indicator for clinical risk screening.

  • Open Access

    Efficacy of Cognitive Behavioral Therapy Combined with Exercise in Patients with Chronic Pain: A Systematic Review and Meta-Analysis [Letter]

    by Qunqi Hu, Nisang Chen

    Letter for the article Efficacy of Cognitive Behavioral Therapy Combined with Exercise in Patients with Chronic Pain: A Systematic Review and Meta-Analysis

  • Open Access

    Current Perspectives and Trend of Acupuncture in Breast Cancer-Related Symptoms: A Bibliometric Study

    by Hanzhi Wang, Siying Qu, Tianshu Zhou, Qunqi Hu, Xiaoxuan Zhao, Qujia Yang, Hengyu Chi, Shiling Luo, Xinyue Li, Huanxiao Ke, et al.

    Purpose: This bibliometric research aims to delineate global publication trends and emerging research interests in the use of acupuncture for breast cancer (BC)-related symptoms treatment over the past three decades. Furthermore, it identifies influential institutions, potential collaborative partners, and future research trends, thereby providing guidance for relevant, novel research directions. Methods: Scientific publications related to acupuncture for BC-related symptoms were gathered from the Web of Science Core Collection (WoSCC) from 1993 to 2023. Four software applications were principally used to analyze the resulting data: the “bibliometrix” package in the R environment (version 4.2.3), VOSviewer, CiteSpace6.1.R6, and the bibliometrics website. These applications were employed to evaluate different parameters. Results: A total of 621 papers on acupuncture in BC-related symptoms treatment were analyzed. The United States, China, and South Korea contributed the most, with Memorial Sloan Kettering Cancer Center, and Columbia University leading institutions. It is interesting to mention that Mao, Jun J. and Molassiotis, A. feature among the top 10 authors and co-cited authors. JAMA is the leading journal, with an ongoing focus on acupuncture’s effectiveness. Keywords show that the initial research focus was mainly on “vasomotor symptoms”, but in recent years there has been a gradual shift towards “pain”, “chemotherapy-induced peripheral neuropathy (CIPN)”, “electroacupuncture”, and “non-specific effects”. Conclusion: Acupuncture has demonstrated a unique value in the process of adjuvant treatment of BC-related symptoms, and has been shown to be effective in reducing pain, eliminating fatigue, and improving quality of life. The study of the mechanisms of acupuncture and the application of electroacupuncture are possible future research priorities in this field. This study offers a deep perspective on acupuncture for BC research, highlighting key points and future trends.


  • Open Access

    Electroacupuncture Alleviates Diabetic Neuropathic Pain and Downregulates p‐PKC and TRPV1 in Dorsal Root Ganglions and Spinal Cord Dorsal Horn

    by Yi-Qi Ma, Qun-Qi Hu, Yu Rong Kang, Li-Qian Ma, Si-Ying Qu, Han-Zhi Wang, Yin-Mu Zheng, Si-Yi Li, Xiao-Mei Shao, Xiao-Yu Li, et al.

    Diabetic neuropathic pain (DNP) is a common complication of diabetes. Streptozotocin (STZ)‐induced changes of protein in dorsal root ganglion (DRG) and spinal cord dorsal horn (SCDH) are critical for DNP genesis. However, which proteins change remains elusive. Here, the DNP model was established by a single intraperitoneal injection of STZ, accompanied by increased fasting blood glucose (FBG), decreased body weight (BW), and decreased paw withdrawal latency (PWL). Proteins change in L4‐L6 DRGs and SCDH of rats were detected. Western blot and immunofluorescence results showed that expression levels of phosphorylated protein kinase C (p‐PKC), transient receptor potential vanilloid‐1 (TRPV1), Substance P (SP) and calcitonin gene‐related peptide (CGRP) in the DRG and the SCDH of rats were increased after STZ injection. A preliminary study from our previous study showed that 2 Hz electroacupuncture (EA) effectively alleviates DNP. However, the analgesic mechanism of EA needs further elucidation. Here, EA at the bilateral Zusanli (ST36) and KunLun (BL60) acupoints was applied for one week, and to investigate the effect on DNP. EA reversed thermal hyperalgesia in DNP rats and downregulated the expression of p‐PKC, TRPV1, SP, and CGRP in DRG and SCDH.


  • [Effect of electroacupuncture and pretreatment of electroacupuncture on pain sensitization and expression of P2X7R in spinal dorsal horn in rats with diabetic neuropathic pain].

    by Qun-Qi Hu, Yi-Qi Ma, Xue-Yu Fei, Lu-Hang Chen, Yu-Rong Kang, Xiang Li, Zhi-Yu Chen, Chen-Lin Jiang, Si-Ying Qu, Han-Zhi Wang, et al.

    To observe the occurrence time of neuralgia and the expression of purinergic ligand-gated ion channel 7 receptor (P2X7R) in the dorsal horn of the spinal cord after intraperitoneal injection of streptozotocin (STZ) in diabetic rats, and to explore the effect of electroacupuncture (EA) and pretreatment of EA on the heat pain threshold and expression of P2X7R in the spinal dorsal horn in rats with diabetic neuropathic pain (DNP), and to explore the possible mechanism of EA for DNP. PartⅠ: Thirty male SD rats were randomly selected from 64 male SD rats as the control group; the remaining rats were given intraperitoneal injection of STZ (10 mg/mL) at a dose of 65 mg/kg to establish the diabetes model, and 30 rats were successfully modeled as the model group. The control group and the model group were divided into three subgroups respectively at 7, 14 and 21 days, with 10 rats in each subgroup. Body mass, fasting blood glucose (FBG) and thermal pain threshold were recorded at 7, 14 and 21 days after injection; the expression of P2X7R in spinal dorsal horn was detected by Western blot. PartⅡ: Eight SD rats were randomly selected from 35 male SD rats as the blank group, and the remaining 27 rats were given intraperitoneal injection of STZ (10 mg/mL) at a dose of 65 mg/kg to establish the diabetes model. The 24 rats with successful diabetes model were randomly divided into a DNP group, an EA group and a pre-EA group, 8 rats in each group. Fifteen to 21 days after STZ injection, the EA group received EA at "Zusanli" (ST 36) and "Kunlun" (BL 60), continuous wave, frequency of 2 Hz, 30 min each time, once a day; the intervention method in the pre-EA group was the same as that in the EA group. The intervention time was 8 to 14 days after STZ injection. The body mass, FBG and thermal pain threshold were recorded before STZ injection and 7, 14 and 21 days after STZ injection; the expression of P2X7R in spinal dorsal horn was detected by Western blot 21 days after injection. PartⅠ: Compared with the control group, in the model group, the body mass was decreased and FBG was increased 7, 14 and 21 days after STZ injection (PPPPPPPP<0.01). The diabetic neuropathic pain is observed 14 days after STZ injection. EA could not only treat but also prevent the occurrence of DNP, and its mechanism may be related to down-regulation of P2X7R expression in the dorsal horn of the spinal cord.